Blue Calypso, Inc.

BCYP

US09531B3024

Software

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2021	Blue Calypso : SAB Biotherapeutics Listed on Nasdaq After Completing Merger With Big Cypress Acquisition	MT
2021	Blue Calypso : Big Cypress Acquisition Shareholders Approve Merger With SAB Biotherapeutics	MT

Ronald L. Chez Asks Bill Ogle, Chief Executive Officer of Blue Calypso to Submit Resignation

September 10, 2014 at 02:33 pm

On September 9, 2014, Ronald L. Chez sent an e-mail to Bill Ogle, Chief Executive Officer of Blue Calypso, Inc. expressing his concern with cash bonus that Bill Ogle were paid in addition to his salary. In addition in his mail, Ronald L. Chez stated that Bill Ogle and the Board have failed in their responsibilities to the Company's shareholders. Furthermore, Ronald L. Chez asked Bill Ogle to submit resignation to the Board of Directors immediately.

Further, Ronald L. Chez announced that he intends to further pursue the matters described in his e-mail (including the immediate removal of the CEO and the directors that he designated). In addition, Ronald L. Chez announced that he has discussed these matters and the future operating plans of the Company with significant shareholders of the Company, and intends to continue to have such discussions.

Latest news about Blue Calypso, Inc.

Blue Calypso : SAB Biotherapeutics Listed on Nasdaq After Completing Merger With Big Cypress Acquisition	21-10-25	MT
Blue Calypso : Big Cypress Acquisition Shareholders Approve Merger With SAB Biotherapeutics	21-10-21	MT
Insider Buy: Big Cypress Acquisition	21-10-05	MT
BLUE CALYPSO : Northland Capital Markets Starts Big Cypress Acquisition Corp at Outperform with $18 Price Target	21-10-04	MT
BLUE CALYPSO : Ladenburg Thalmann Initiates Big Cypress Acquisition at Buy Rating With $16.50 Price Target	21-10-01	MT
Blue Calypso : SAB Biotherapeutics Gets Safety Monitoring Board's Recommendation to Advance COVID-19 Drug Candidate to Phase 3 Trial	21-09-24	MT
Blue Calypso : Big Cypress Acquisition Sets Shareholder Vote to Approve Merger With SAB Biotherapeutics	21-09-23	MT
Blue Calypso : SAB Biotherapeutics Awarded Additional $60.5 Million by Defense Department for COVID-19 Drug Candidate Program	21-09-22	MT
BIG CYPR : Cypress Acquisition Closes $115 Million Initial Public Offering	21-01-14	MT
Blue Calypso To Explore Strategic Alternatives	16-12-20	CI
Transcript : Blue Calypso, Inc., Q3 2016 Earnings Call, Nov 10, 2016	16-11-10
Blue Calypso, Inc. Reports Unaudited Consolidated Financial Results for the Third Quarter and Nine Months Ended September 30, 2016	16-11-10	CI
Blue Calypso, Inc. Announces Management Changes	16-10-18	CI
Blue Calypso, Inc. Announce the Resignation of Melisse Shaban as Member of the Board of Directors	16-08-26	CI
Transcript : Blue Calypso, Inc., Q2 2016 Earnings Call, Aug 10, 2016	16-08-10
Blue Calypso, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016	16-08-10	CI
Blue Calypso, Inc. Appoints Harold Hal Brierley as Chairman of the Board	16-07-26	CI
Blue Calypso, Inc. Reports Unaudited Consolidated Earnings Results for Its First Quarter Ended March 31, 2016	16-05-16	CI
Transcript : Blue Calypso, Inc., Q1 2016 Earnings Call, May 16, 2016	16-05-16
Blue Calypso, Inc. announced that it has received $1 million in funding	16-04-21	CI
Blue Calypso, Inc. Reports Earnings Results for the Year Ended December 31, 2015	16-03-22	CI
Transcript : Blue Calypso, Inc., Q4 2015 Earnings Call, Mar 22, 2016	16-03-22
Blue Calypso, Inc. announced that it has received $0.05 million in funding	16-03-03	CI
Blue Calypso, Inc. announced that it has received $0.35 million in funding	16-03-01	CI
Blue Calypso, Inc. announced that it expects to receive $0.35 million in funding	16-02-16	CI

Chart Blue Calypso, Inc.

Duration

Period

More charts

Company Profile

Blue Calypso, Inc. is a United States-based company. The Company develops and delivers mobile shopper marketing and analytics solutions for the business-to-consumer (B2C) marketplace leveraging mobile, social media, gamification and intellectual property portfolio. The Company offers, KIOSENTRIX, provides manufacturers and brick-and-mortar retailers with a personalized way of engaging with store visitors when they are on the path-to-purchase. Its platform allows the collection of business intelligence and analytics resulting from data accumulated as content is deployed, adopted, consumed and shared. Its technology allows the brand/advertiser to monitor the full cycle of a campaign, from the first engagement to the final redemption or intent to purchase. In addition, the Company offers outsourced consulting and customized software development services through Blue Calypso Labs services.

Sector

Software

More about the company

Sector Other Software

	1st Jan change	Capi.
BLUE CALYPSO, INC.	-.--%	76.63K
MICROSOFT CORPORATION	+14.39%	3,197B
SYNOPSYS INC.	+14.08%	89.6B
CADENCE DESIGN SYSTEMS, INC.	+8.04%	80.08B
DASSAULT SYSTÈMES SE	-12.11%	55.52B
PALANTIR TECHNOLOGIES INC.	+22.36%	46.79B
THE TRADE DESK, INC.	+31.67%	46.34B
ATLASSIAN CORPORATION	-29.01%	43.95B
SEA LIMITED	+77.73%	41.34B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-3.95%	26.5B

Other Software

Blue Calypso, Inc.

Equities

BCYP

US09531B3024

Software

Ronald L. Chez Asks Bill Ogle, Chief Executive Officer of Blue Calypso to Submit Resignation

Latest news about Blue Calypso, Inc.

Chart Blue Calypso, Inc.

Company Profile

Sector Other Software